Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Stanford researchers develop gene therapy technique that sharply cuts risks

14.10.2002


Researchers at Stanford University Medical Center have devised a new gene therapy technique that appears to eliminate one of the major health risks linked to gene therapy. The technique, published in the Oct. 15 advanced online edition of the journal Nature Biotechnology, overcomes the need for viral vectors that have plagued gene therapy trials, while retaining the ability to insert therapeutic DNA into specific sites in the chromosomes.



"Our approach provides an alternative that didn’t exist before," said Michele Calos, PhD, associate professor of genetics at the School of Medicine and lead author on the study.

The goal of gene therapy is to insert a healthy copy of a gene into a cell where it can take over for a faulty version. If the therapeutic DNA does not integrate into the human chromosome, it produces its protein for a short time before being turned off or broken down within the cell. For a long-term cure, the gene has to wedge itself into a chromosome where it remains indefinitely integrated, getting passed on when the cell divides.


Current gene therapy approaches that cause genes to integrate use a viral vector to sneak the therapeutic DNA into the host cell, Calos said. However, the DNA inserts itself into the chromosome at random positions. In one recent French gene therapy trial, the randomly inserted DNA apparently activated a neighboring oncogene, causing a patient to develop leukemia. "That sort of puts another cloud over the existing gene therapy trials," Calos said.

Calos’ technique avoids the pitfalls of other gene therapy approaches by integrating DNA without using viral vectors, inserting the DNA at known locations. This new technique can also handle genes that are too large to fit into a viral package, such as the gene for Duchenne’s muscular dystrophy, Calos said.

In developing this new approach, Calos hijacked a mechanism used by a bacteria-infecting virus (called a bacteriophage) to integrate its genes into bacteria. The bacteriophage makes a protein called integrase that inserts the viral genes into a specific DNA sequence on the bacteria chromosome. It turns out that humans also have a version of that DNA sequence. When the researchers insert a copy of the therapeutic gene and a gene coding for integrase into a human cell, the integrase inserts the gene within the human sequence.

Calos and members of her lab, in collaboration with Mark Kay, MD, PhD, professor of pediatrics and genetics, tested the technique using a gene that makes Factor IX - a protein that is missing in the blood of people with one form of hemophilia. They injected mice with a piece of DNA containing the Factor IX gene plus a stretch of DNA that acts as an "insert me" signal to integrase. At the same time they injected a gene for integrase.

Within a week, mice that received this injection made 12 times more Factor IX than their littermates that received the injection without the integrase. Further experiments confirmed that the Factor IX gene had successfully integrated into the mouse DNA.

Although the mouse genome contains at least 53 potential integration sites, Calos and her team found the Factor IX gene in only two locations, with one location by far the more common. She said that for each tissue there may be a particular site that is the most likely insertion point. Her group is testing the technique in different tissue types to ensure that no human integration site is near a potential oncogene. "We need to look in different tissues to see where the hot spot is," Calos said.

Calos is also modifying the integrase so it targets specific integration sites that her team knows are safe. "We mutated the enzyme and evolved it so it will prefer one place over another," she said.

Calos said this approach should be effective for treating diseases in several different human organs including skin, retina, blood, muscle and lung. She hopes to start human trials for the technique in a fatal childhood skin disease called recessive dystrophic epidermolysis bullosa, which she has already treated in mice. "If that trial shows that it is safe then that will open the door for trials in other diseases," Calos said. She has collaborations underway testing the technique for use in Duchenne’s muscular dystrophy and cystic fibrosis, among others.


Contributing researchers to the study include Stanford graduate students Eric Olivares and Thomas Chalberg, and post-doctoral scholar Roger Hollis, PhD.

Stanford University Medical Center integrates research, medical education and patient care at its three institutions - Stanford University School of Medicine, Stanford Hospital & Clinics and Lucile Packard Children’s Hospital at Stanford.

Amy Adams | EurekAlert!
Further information:
http://mednews.stanford.edu

More articles from Health and Medicine:

nachricht Purdue cancer identity technology makes it easier to find a tumor's 'address'
16.11.2018 | Purdue University

nachricht Microgel powder fights infection and helps wounds heal
14.11.2018 | Michigan Technological University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: UNH scientists help provide first-ever views of elusive energy explosion

Researchers at the University of New Hampshire have captured a difficult-to-view singular event involving "magnetic reconnection"--the process by which sparse particles and energy around Earth collide producing a quick but mighty explosion--in the Earth's magnetotail, the magnetic environment that trails behind the planet.

Magnetic reconnection has remained a bit of a mystery to scientists. They know it exists and have documented the effects that the energy explosions can...

Im Focus: A Chip with Blood Vessels

Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.

Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...

Im Focus: A Leap Into Quantum Technology

Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.

In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...

Im Focus: Research icebreaker Polarstern begins the Antarctic season

What does it look like below the ice shelf of the calved massive iceberg A68?

On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.

Im Focus: Penn engineers develop ultrathin, ultralight 'nanocardboard'

When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure

Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

“3rd Conference on Laser Polishing – LaP 2018” Attracts International Experts and Users

09.11.2018 | Event News

On the brain’s ability to find the right direction

06.11.2018 | Event News

European Space Talks: Weltraumschrott – eine Gefahr für die Gesellschaft?

23.10.2018 | Event News

 
Latest News

Purdue cancer identity technology makes it easier to find a tumor's 'address'

16.11.2018 | Health and Medicine

Good preparation is half the digestion

16.11.2018 | Life Sciences

Microscope measures muscle weakness

16.11.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>